EGFR Kit of AmoyDx, China, Supplier to MoBiTec, Germany, Ranks Top in 2014 Lung Cancer EMQN Report

Goettingen, Germany, December 11, 2014 --(PR.com)-- Amoy Diagnostics, located in Xiamen, China, provides state-of-the-art molecular diagnostic products and services to healthcare providers, academic institutions, and pharmaceutical companies. The company has a rich portfolio of tests that focuses on detecting mutations and measuring gene expression in FFPE cancer tissue.

The company supplies EGFR tests to AstraZeneca in China, and also supplies ROS1 tests for pivotal clinical trials of Pfizer´s crizotinib in China, Korea, and Japan.

Now, the 2014 independent Quality Assessment Scheme for Lung Cancer carried out by the European Molecular Genetics Quality Network (EMQN) ranks AmoyDx's EGFR kit the top among other suppliers.

Next to the EGFR kit, the following kits are approved for CE-IVD in Europe and CFDA for clinical use in China:

• KRAS
• BRAF
• PIK3CA
• EML4-ALK
• ROS1
• ALK/ROS1
• NRAS
• KRAS/NRAS
• RET
• ERCC1

Earlier this year MoBiTec GmbH, Germany, signed a distribution agreement with AmoyDx for the German market.

About MoBiTec GmbH

MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.